The Evrysdi trial program is assessing efficacy and safety in a wide range of people with SMA 1,6

The efficacy and safety of Evrysdi are being studied in infants, children, and adults

Evrysdi is being evaluated in 3 clinical trials 1,7
 

FIREFISH trial details

SUNFISH trial details

JEWELFISH trial details

*Enrollment across 3 clinical trials.
Infantile-onset SMA defined as Type 1 SMA; later-onset SMA defined as Type 2 or Type 3 SMA.
BSID-III=Bayley Scales of Infant and Toddler Development–Third Edition; MFM-32=Motor Function Measure-32 Items.